Evidence for non-linear pharmacokinetics of oxytocin in anesthetized rat

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 11, Issue 4, 2008, Pages 12-24

  Morin, Valérie ^a   del Castillo, Jérôme R E ^a   Authier, Simon ^a,b   Ybarra, Norma ^a   Otis, Colombe ^a   Gauvin, ominique ^a   Gutkowska, Jolanta ^c   Troncy, Éric ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAB Research Inc   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN;

ANESTHESIA; ANIMAL; ARTICLE; BLOOD; DRUG ADMINISTRATION ROUTE; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; NONLINEAR SYSTEM; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANESTHESIA; ANIMALS; DRUG ADMINISTRATION ROUTES; INJECTIONS, INTRAVENOUS; MALE; NONLINEAR DYNAMICS; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 65249096120     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3pk5x     Document Type: Article

References (54)

1. Dudley DJ. Oxytocin: use and abuse, science and art. Clin Obstet Gynecol, 1997; 40:516-524.
2. Al-Eknah MM, Homeida AM. A review of some aspects of the pharmacology of oxytocin in domestic animals. Vet Res Commun, 1991; 15:45-55.
3. Ashton N, Balment RJ. Sexual dimorphism in renal function and hormonal status of New Zealand genetically hypertensive rats. Acta Endocrinol (Copenh), 1991; 124(1):91-97.
4. Leake RD, Weitzman RE, Fisher DA. Pharmacokinetics of oxytocin in the human subject. Obstet Gynecol, 1980; 56(6):701-704.
5. Paquin J, Danalache BA, Jankowski M, McCann SM, Gutkowska J. Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci U S A; 2002, 99(14):9550-9555.
6. Jankowski M, Danalache BA, Wang D, Bhat P, Hajjar F, Marcinkiewicz M, Paquin J, McCann SM, Gutkowska J. Oxytocin in cardiac ontogeny. Proc Natl Acad Sci U S A; 2004; 101:13074-13079.
7. Matsuura K, Nagai T, Nishigaki N, Oyama T, Nishi J, Wada H, Sano M, Toko H, Akazawa H, Sato T, Nakaya H, Kasanuki H, Komuro I. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem, 2004; 279:11384-11391.
8. Thibonnier T, Conarty DM, Preston JA, Plesnicher CL, Dweik RA, Erzurum SC. Human vascular endothelial cells express oxytocin receptors. Endocrinology, 1999; 140(3):1301-1309.
9. Jankowski M, Danalache BA, Gutkowska J. Cterminal oxytocin peptides induce cardiomyogenesis. [Abstract P112] Hypertension, 2005; 46(5):851.
10. Danalache BA, Paquin J, Donghao W, Grygorczyk R, Moore JC, Mummery CL, Gutkowska J, Jankowski M. Nitric oxide signaling in oxytocin-mediated cardiomyogenesis. Stem Cells, 2007; 25(3):679-688.
11. Seitchik J, Amico J, Robinson AG, Castillo M. Oxytocin augmentation in dysfunctional labor IV. Oxytocin pharmacokinetics. Am J Obstet Gynecol, 1984; 150(3):225-228.
12. Homeida AM, Cooke RG. Biological half-life of oxytocin in the goat. Res Vet Sci, 1984; 37:364-365.
13. Thornton S, Davison JM, Baylis PH. Effect of human pregnancy on metabolic clearance rate of oxytocin. Am J Physiol, 1990; 259:R21-R24.
14. Lundin S, Broeders A, Ohlin M, Hansson K, Bengtsson H-I, Trojnar J, Melin P. Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat. J Pharmacol Exp Ther, 1993; 264(2):783-788.
15. De Groot ANJA, Vree TB, Hekster YA, Pesman GJ, Sweep FCGJ, Van Dongen PJW, Van Roosmalen J. Bioavailability and pharmacokinetics of sublingual oxytocin in male volunteers. J Pharm Pharmacol, 1995; 47:571-575.
16. Jankowski M, Hajjar F, Al Kawas S, Mukaddam-Daher S, Hoffman G, McCann SM, Gutkowska J. Rat heart: A site of oxytocin production and action. Proc Natl Acad Sci U S A, 1998; 95:14558-14563.
17. Favaretto ALV, Ballejo GO, Albuquerque-Araújo WIC, Gutkowska J, Antunes-Rodrigues J, McCann SM. Oxytocin releases atrial natriuretic peptide from rat atria in vitro that exerts negative inotropic and chronotropic action. Peptides, 1997; 18(9):1377-1381.
18. Gutkowska J, Jankowski M, Lambert C, Mukaddam-Daher S, Zingg HH, McCann SM. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci U S A, 1997; 94:11704-11709.
19. Gutkowska J, Jankowski M, Mukaddam-Daher S, McCann SM. Oxytocin is a cardiovascular hormone. Braz J Med Biol Res, 2000; 33(6):625-633.
20. Mukaddam-Daher S, Yin Y-L, Roy J, Gutkowska J, Cardinal R. Negative inotropic and chronotropic effects of oxytocin. Hypertension, 2001; 38:292-296.
21. Petersson M, Alster P, Lundeberg T, Uvnäs-Moberg K. Oxytocin causes a long-term decrease of blood pressure in female and male rats. Physiol Behav, 1996; 60(5):1311-1315.
22. Nakano J, Fisher DR. Studies on the cardiovascular effects of synthetic oxytocin. J Pharmacol Exp Ther, 1963; 142:206-214.
23. Armour JA, Yuan BX, Butler CK. Cardiac responses elicited by peptides administered to canine intrinsic cardiac neurons. Peptides, 1990; 11(4):753-761.
24. Neath PJ, Brown DC, Hughes D, Perkowski SZ. The hemodynamic effects of intrathecal oxytocin in normal dogs. Vet Surg, 2000; 29:272-277.
25. Rasmussen MS, Simonsen JA, Sandgaard NCF, Høilund-Carlsen PF, Bie P. Effects of oxytocin in normal man during low and high sodium diets. Acta Physiol Scand, 2004; 181:247-257.
26. Fraser AM. Actions of oxytoxic hormone of pituitary gland on urine secretion. J Physiol, 1942; 101:238-251.
27. Sawyer WH. Posterior pituitary extracts and excretion of electrolytes by the rat. Am J Physiol, 1952; 16:583-87.
28. Chan WY, Du Vigneaud V. Natriuretic, diuretic and anti-arginine-vasopressin (ADH) effects of two analogs of oxytocin: [4-leucine]-oxytocin and [2,4-diisoleucine]-oxytocin. J Pharmacol Exp Ther, 1970; 174(3):541-549.
29. Verbalis JG, Mangione MP, Stricker EM. Oxytocin produces natriuresis in rats at physiological plasma concentrations. Endocrinology, 1991; 128(3):1317-1322.
30. Conrad KP, Gellai M, North WG, Valtin H. Influence of oxytocin on renal hemodynamics and sodium excretion. Ann N Y Acad Sci, 1993; 689:346-362.
31. Sjöquist M, Huang W, Jacobsson E, Skøtt O, Stricker EM, Sved AF. Sodium excretion and renin secretion after continuous versus pulsatile infusion of oxytocin in rats. Endocrinology, 1999; 140(6):2814-2818.
32. Brooks FP, Pickford M. The effect of posterior pituitary hormones on the excretion of electrolytes, in dogs. J Physiol, 1958; 142:468-493.
33. Chan WY, Sawyer WH. Saluretic actions of neurohypophysial peptides in conscious dogs. Am J Physiol, 1961; 201:799-803.
34. Kostoglou-Athanassiou I, Treacher DF, Forsling ML. Is oxytocin natriuretic in man? J Endocrinol, 1994; 143(Suppl. O):39.
35. Conrad KP, Gellai M, North WG, Valtin H. Influence of oxytocin on renal hemodynamics and electrolyte and water excretion. Am J Physiol, 1986; 251:F290-F296.
36. Soares TJ, Coimbra TM, Martins AR, Pereira AGF, Carnio EC, Branco LGS, Albuquerque-Araújo WIC, De Nucci G, Favaretto ALV, Gutkowska J, McCann SM, Antunes-Rodrigues J. Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP. Proc Natl Acad Sci U S A, 1999; 96:278-283.
37. Baird S, Pickford M. The simultaneous occurence of certain changes in uterine and renal activity in dogs, and the role of oxytocin in these phenomena. J Physiol, 1958; 144:80-91.
38. Andersen SE, Engstrom T, Bie P. Effects on renal sodium and potassium excretion of vasopressin and oxytocin in conscious dogs. Acta Physiol Scand, 1992; 145:267-274.
39. Gabrielsson, J.L.; Weiner, D., Pharmacokinetic and Pharmacodynamic data analysis, Concepts and Applications, 2nd ed., Swedish Pharmaceutical Press, Stockholm, Sweden, 1997.
40. D'Argenio, D.Z.; Schumitzky, A., ADAPT II user's guide pharmacokinetic/ pharmacodynamic systems analysis software. Biomedical Simulations Resource, Los Angeles, CA, USA, 1997.
41. Gibaldi, M.; Perrier, D., Pharmacokinetics, 2nd ed., Marcel Dekker, Inc, New York, NY, USA, 1982.
42. Neter, J., Applied linear statistical models: regression, analysis of variance and experimental designs, Neter, J.; Wasserman, W.; Kutner, M.H., 3rd ed., Richard D. Irwin, Inc, Homewood, IL, U S A, 1990.
43. Bonate, P.L., Pharmacokineticphamacodynamic modeling and simulation. Springer, Inc, New York, NY, USA, 2005.
44. Kowalski WB, Diveky L, Mehendale R, Parsons M, Wilson L Jr. Effect of pregnancy on the metabolic clearance rate and the volume of distribution of oxytocin in the baboon. Am J Physiol, 1998; 274:E791-E795.
45. Fabian M, Forsling ML, Jones JJ, Lee J. The release, clearance and plasma protein binding of oxytocin in the anaesthetized rat. J Endocrinol, 1969; 43:175-189.
46. Gimpl G, Farenholtz F. The oxytocin receptor system: Structure, function and regulation. Physiol Rev, 2001; 81(2):629-683.
47. Nakamura H, Itakuara A., Okamura M, Ito M, Iwase A, Nakanishi Y, Okada M, Nagasaka T, Mizutani S. Oxytocin stimulates the translocation of oxytocinase of human endothelial cells via activation of oxytocin receptors. Endocrinology, 2000; 141(12):4481-4485.
48. Tsujimoto M, Hattori A. The oxytocinase subfamily of M1 aminopeptidases. Biochim Biophys Acta, 2005; 1751:9-18.
49. Guzzi F, Zanchetta D, Cassoni P, Guzzi V, Francolini M, Parenti M, Chini B. Localization of the human oxytocin receptor in calveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response. Oncogene, 2002; 21:1658-1667.
50. Arpin-Bott MP, Waltisperger E, Freund-Mercier MJ, Stoeckel ME. Two oxytocin binding subtypes in rat kidney: pharmacological characterization, ontogeny and localisation by in vitro and in vivo autoradiography. J Endocrinol, 1997; 153(1):49-59.
51. Costa-e-Sousa RH, Pereira-Junior PP, Oliveira PF, Olivares EL, Werneck-de-Castro JPS, Mello DB, Nascimento JHM, Campos-de-Carvalho AC. Cardiac effets of oxytocin: Is there a role for this peptide in cardiovascular homeostasis? Regul Pept, 2005; 132:107-112.
52. Han JS, Macda Y, Knepper MA. Dual actions of vasopressin and oxytocin in regulation of water permeability in terminal collecting duct. Am J Physiol, 1993; 265:F26-F34.
53. Wargent ET, Burgess WJ, Laycock JF, Balment RJ. Separate receptors mediate oxytocin and vasopressin stimulation of cAMP in rat inner medullary collecting duct cells. Exp Physiol, 1999; 84:17-25.
54. Joo KW, Jeon US, Kim G-H, Park J, Oh YK, Kim YS, Ahn C, Kim S, Kim SY, Lee JS, Han JS. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2. Nephrol Dial Transplant, 2004; 19:2480-2486.